Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Group Therapy -- Ignore unavailable to you. Want to Upgrade?

To: E. Graphs who wrote (1286)	4/30/2000 11:05:00 PM
From: Duane L. Olson	Respond to of 4564

E! Oh my, that is an exciting biotech achievement... Thanks so much!! My understanding is that the top 100 biotech firms have 140 drugs in final stages. Should be an explosion of reports like the one you've found here coming up over the next few months. I've increased my mutual fund holdings in that arena, because it is nearly impossible to pick winners in this game. My exception is NERX, because they have already had such proven success in anti-cancer trials. So I have picked up a few shares again. But their profitability is still a couple of years away, and earnings are King right now. So perhaps "other" techs are the game to play for now, wouldn't you think? tso

To: E. Graphs who wrote (1286)	5/1/2000 1:14:00 AM
From: Duane L. Olson	Read Replies (1) \| Respond to of 4564

E! Check this chart on a mutual fund: First Hand's Tech Leaders Fund. siliconinvestor.com Doesn't this chart seem to give a perfect picture of the "head and shoulders" that led into the drop, as well as current recovery?... Better than the "Naz" in some ways, imho.. tso